These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Periconceptional nonsteroidal anti-inflammatory drug use, folic acid intake, and the risk of spina bifida. Esposito DB, Parker SE, Mitchell AA, Tinker SC, Werler MM. Birth Defects Res; 2021 Oct 15; 113(17):1257-1266. PubMed ID: 34346174 [Abstract] [Full Text] [Related]
3. Folic acid intake and spina bifida in the era of dietary folic acid fortification. Ahrens K, Yazdy MM, Mitchell AA, Werler MM. Epidemiology; 2011 Sep 15; 22(5):731-7. PubMed ID: 21659881 [Abstract] [Full Text] [Related]
4. Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects. Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM. Ann Epidemiol; 2017 Dec 15; 27(12):777-782.e1. PubMed ID: 29133009 [Abstract] [Full Text] [Related]
5. Maternal tea consumption during early pregnancy and the risk of spina bifida. Yazdy MM, Tinker SC, Mitchell AA, Demmer LA, Werler MM. Birth Defects Res A Clin Mol Teratol; 2012 Oct 15; 94(10):756-61. PubMed ID: 22641606 [Abstract] [Full Text] [Related]
6. Association between maternal pregestational diabetes mellitus and spina bifida: A population-based case-control study, Finland, 2000-2014. Mowla S, Gissler M, Räisänen S, Kancherla V. Birth Defects Res; 2020 Jan 15; 112(2):186-195. PubMed ID: 31774241 [Abstract] [Full Text] [Related]
7. Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study. De Marco P, Merello E, Calevo MG, Mascelli S, Pastorino D, Crocetti L, De Biasio P, Piatelli G, Cama A, Capra V. Childs Nerv Syst; 2011 Jul 15; 27(7):1073-81. PubMed ID: 21207040 [Abstract] [Full Text] [Related]
10. Prevention of spina bifida: folic acid intake during pregnancy in Gulu district, northern Uganda. Bannink F, Larok R, Kirabira P, Bauwens L, van Hove G. Pan Afr Med J; 2015 Jul 15; 20():90. PubMed ID: 26090048 [Abstract] [Full Text] [Related]
11. Arsenic modifies the effect of folic acid in spina bifida prevention, a large hospital-based case-control study in Bangladesh. Wei CF, Mukherjee SK, Ekramullah SM, Arman DM, Islam MJ, Azim M, Rahman A, Rahman MN, Ziauddin M, Tindula G, Suchanda HS, Gomberg DF, Weisskopf MG, Liang L, Warf BC, Christiani DC, Mazumdar M. Environ Health; 2024 Jun 03; 23(1):51. PubMed ID: 38831396 [Abstract] [Full Text] [Related]
15. Risk of spina bifida and maternal cigarette, alcohol, and coffee use during the first month of pregnancy. Benedum CM, Yazdy MM, Mitchell AA, Werler MM. Int J Environ Res Public Health; 2013 Aug 02; 10(8):3263-81. PubMed ID: 23917813 [Abstract] [Full Text] [Related]
16. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. Am J Med Genet; 2002 Feb 15; 108(1):1-6. PubMed ID: 11857541 [Abstract] [Full Text] [Related]
19. Survival of infants with spina bifida and the role of maternal prepregnancy body mass index. Pace ND, Siega-Riz AM, Olshan AF, Chescheir NC, Cole SR, Desrosiers TA, Tinker SC, Hoyt AT, Canfield MA, Carmichael SL, Meyer RE, National Birth Defects Prevention Study. Birth Defects Res; 2019 Oct 01; 111(16):1205-1216. PubMed ID: 31322328 [Abstract] [Full Text] [Related]